fashion -WSS

fashion

author：knowledge 2025-10-01 03:49:24 - browse：81

Robert F. Kennedy Jr. said Tuesday that he will head up a panel on vaccine safety for Donald Trump.

The president-elect’s transition team spokeswoman later walked that back, saying that he is “exploring the possibility” of forming a panel on autism, but “no decisions have been made.”

Let’s hope Trump drops any idea of a vaccine panel headed by Kennedy. For more than a decade, Kennedy has promoted anti-vaccine propaganda completely unconnected to reality. If Kennedy’s panel leads to even a small decline in vaccine rates across the country, it will result in the waste of untold amounts of money and, in all likelihood, the preventable deaths of infants too young to be vaccinated.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： New Covid vaccine is recommended for everyone 6 months or older

focus

WSS

FDA's Woodcock to retire early next year

Hospitals look to new technology to keep health care workers safe

How medical schools plan to diversify without affirmative action

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

PBM reforms clear House panel

FDA panel endorses Alnylam’s heart drug — after picking it apart

leisure time

fashion

hotspot

Supreme Court strikes down use of affirmative action

Diverse clinical trials: Why aren’t we there yet?

Moonlake's readout produced a cash windfall. Risks remain

NYU radiologists take on the challenge of expensive MRI machines

Activists slam private health insurers over coverage restrictions

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

In age of alternative facts, a scholarly course on calling out crap

New Covid vaccine is recommended for everyone 6 months or older

State Dept. review finds Biden bears some blame for Afghanistan failures

A common UTI test for kids haunts adults as a traumatic 'nightmare'

entertainment

Generate Biomedicines machine learning biotech raises $273M

FDA's Woodcock to retire early next year

Weight loss drug costs may need more research, senator suggests

Weight loss drug costs may need more research, senator suggests

How medical schools plan to diversify without affirmative action

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

focus

hotspot

focus

explore